Crean T I, John M, Calderwood S B, Ryan E T
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Infect Immun. 2000 Feb;68(2):977-81. doi: 10.1128/IAI.68.2.977-981.2000.
The germfree mouse model of Vibrio cholerae infection can be used to judge immune responses to V. cholerae vaccine and vector strains. In the original model, a single oral inoculation was administered on day 0, a booster oral inoculation was administered on day 14, and immune responses were analyzed with samples collected on day 28. Unfortunately, immune responses in this model frequently were low level, and interanimal variability occurred. In order to improve this model, we evaluated various primary and booster V. cholerae inoculation schedules. The most prominent systemic and mucosal antibody responses were measured in mice that received a multiple primary inoculation series on days 0, 2, 4, and 6 and booster inoculations on days 28 and 42. These modifications result in improved preliminary evaluation of V. cholerae vaccine and vector strains in mice.
霍乱弧菌感染的无菌小鼠模型可用于判断对霍乱弧菌疫苗和载体菌株的免疫反应。在原始模型中,于第0天进行单次口服接种,第14天进行加强口服接种,并在第28天采集样本分析免疫反应。遗憾的是,该模型中的免疫反应常常处于低水平,且存在动物个体间差异。为改进此模型,我们评估了多种霍乱弧菌初次接种和加强接种方案。在第0、2、4和6天接受多次初次接种系列,并在第28和42天接受加强接种的小鼠中,检测到了最显著的全身和黏膜抗体反应。这些改进使得对小鼠体内霍乱弧菌疫苗和载体菌株的初步评估得到改善。